Company Liquidation LTD

Company profile

Cadscan Limited

Cadscan Limited is a UK company with status liquidation founded in 2011.

CRN
07486642
Founded
2011
Age
15

Overview

Legal name
CADSCAN LIMITED
Region
Unknown
Registered address
Unknown
Insolvency history
Yes

Company events

Reference milestones and recent Companies House filing stream events.

2 events
02 Sep
2024

Liquidation Voluntary Creditors Return Of Final Meeting

Insolvency

LIQ14 | Transaction MzQzMzQzMDc3MmFkaXF6a2N4 | Paper/PDF filed

Published 03 Sep 2024 07:02

10 Jan
2011

Incorporated

Inception

Company registered at Companies House

Public funding

25 awards
First funded
2012
Funded years
2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020
Age at first award
1 years

Projects

2020 Collaborative R&D Lead participant

Digitising in-store footwear retail

1 Nov 2020 to 30 Apr 2021

Awarded
£99,983
Total cost £99,983

In 2019 218m items of footwear were sold in the UK generating sales of £10.5b, and 100,000 people are employed in retail and wholesale. The impact of Covid-19 has been severe causing a 30% sales drop because of reduced demand. Excess stock, numerous store closures and redundancies are likely to make recovery slow. Online sales accounted for 27% of footwea...

2020 Feasibility Studies Lead participant

Virtue: A VR system for the cognitive rehabilitation of stroke patients - Continuity Grant

1 Jun 2020 to 30 Nov 2020

Awarded
£65,743
Total cost £65,743

no public description

2019 Collaborative R&D Lead participant

A feasibility study for a custom foot orthotic kiosk

1 Sep 2019 to 31 Aug 2020

Awarded
£56,524
Total cost £80,748

We aim to establish the feasibility of a disruptive, novel, low-cost, fully automated and compact 3D imaging and printer kiosk. It will be available in high-street retailers (e.g. pharmacists) to scan customer's feet, automatically design and then print custom orthotic insoles on demand, within 1-2 hours. No current solution manufactures custom orthoses o...

2018 Feasibility Studies Lead participant

Low-cost in-shoe pressure measurement

1 Dec 2018 to 30 Nov 2019

Awarded
£72,332
Total cost £103,333

"The successful completion of this feasibility project will generate a novel measurement system for assessing the loading that is applied on the foot-at-risk of developing a foot ulcer during activities of daily living. It therefore would have significant potential for disease prevention and proactive management of health and chronic conditions. This nove...

2018 Collaborative R&D Lead participant

VIRTUE - Virtual Reality for Cognitive Stroke Rehabilitation

1 Sep 2018 to 28 Feb 2021

Awarded
£190,887
Total cost £272,695

Globally, there are 15m strokes annually. Most people survive a first stroke but often have significant morbidity. In addition to motor disability a third have a significant cognitive impairment affecting their functional ability and require substantial socio-economic and financial support, sometimes for the rest of their lives. Strokes cost the UK £9 bil...

2018 Feasibility Studies Lead participant

3D perfusion mapping for diabetic foot ulcer assessment

1 Aug 2018 to 31 Jul 2019

Awarded
£94,431
Total cost £134,902

"3.7m people in the UK and 422m worldwide have diabetes. Diabetic Foot Ulceration (DFU) is the most common complication, with over 60,000 people having an ulcer at any time, costing the NHS £650m annually. 40% of patients reulcerate within 1 year and 60% within 3 years. In the UK this results in 7,300 amputations per year, 20 every day. Patients who have ...

2017 Collaborative R&D Lead participant

GUFO: An airborne robotic assistant for older people

1 Aug 2017 to 31 Jan 2019

Awarded
£109,171
Total cost £155,959

Improved life expectancy is set to become one of the greatest challenges of the 21st century. There are more than 1.5m over 85s currently in the UK, 66% of whom have a disability or longstanding illness. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. 80% of seniors would prefer to “age in ...

2017 Feasibility Studies Lead participant

3D Screen Printing

1 Jul 2017 to 31 Mar 2018

Awarded
£42,645
Total cost £60,922

The transition from manufacturing prototype plastoc parts to production parts involves significant investment, particularly with injection moulding where high tooling and design costs require high-volume production to be economically viable. While additive manufacturing reduces design risk it is generally unsuitable for production due to limited materials...

2017 Collaborative R&D Lead participant

A low-cost wound management system for primary care

1 Jun 2017 to 28 Feb 2019

Awarded
£217,419
Total cost £310,598

The treatment and management of wounds is a significant burden for healthcare providers. A recent study found that the NHS treats an estimated 2.2 million wounds per year, with an annual cost of £5.3 billion. Nearly £1.2m of these costs resulted from hospital admissions and day cases, and a further £1.2m in drug prescriptions. Wound management is predomin...

2017 Feasibility Studies Lead participant

ViscoTurf - Treatment of Diabetic Foot Ulceration

1 Feb 2017 to 31 Jan 2018

Awarded
£68,894
Total cost £98,420

Diabetic foot ulcers are a major source of morbidity and resource use for patients with diabetes. According to NHS England, 3.2m people in the UK have diabetes and the worldwide diabetic population was 422m in 2014. The lifetime risk of a diabetic foot ulcer is 25%, with 15% of these leading to amputation, 85% of all lower-limb amputations. In the UK an e...

2017 Feasibility Studies Lead participant

A low-cost robotic inspection platform for remote operation in aggressive environments

1 Jan 2017 to 31 Dec 2017

Awarded
£66,308
Total cost £94,726

Inspection in aggressive environments is time-consuming, dangerous and expensive. We will address this by developing a low-cost, autonomous robot platform based on Cadscan’s novel, patent-pending 3D imaging technology. This uses multi-illuminator phase-shifting to capture high resolution imagery inexpensively using just an array of LEDs, a printed mask an...

2017 Feasibility Studies Lead participant

Building International partnerships for Diabetic Foot Ulcer solutions

1 Jan 2017 to 31 Mar 2017

Awarded
£20,832
Total cost £29,760

Diabetes affects 422m people worldwide (WHO) and accounts for 12% of global health expenditure when related complications are included. Diabetic foot ulcers are a major source of morbidity and resource use for patients with diabetes. 28% may result in amputation although 80% of these are preventable. 56% of people with diabetes who have had ulcers survive...

Product types

Collaborative R&D Feasibility Studies GRD Development of Prototype GRD Proof of Market Vouchers